Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease

@inproceedings{Ho2019MetforminUM,
  title={Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease},
  author={Te-Wei Ho and Chun-Ta Huang and Yi-Ju Tsai and Angela Shin-Yu Lien and Feipei Lai and Chong-Jen Yu},
  booktitle={Respiratory research},
  year={2019}
}
Background and objectiveAmong patients with chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM) is a common comorbidity and is probably associated with increased systemic inflammation and worse prognosis. Metformin, with its pleiotropic anti-inflammatory and antioxidant actions, may offer theoretical benefits in COPD patients with DM. Thus, this study aimed to investigate the effects of DM and metformin use on mortality in the clinical trajectory of COPD.MethodsThis was a… CONTINUE READING
BETA

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges.

José Luis López-Campos, Juan José Soler-Cataluña, Marc Miravitlles
  • 2019
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL